SelectION

San Diego, CA · Founded 2002 · Privately Held (backing)

Developer of peptide therapeutics designed to assist in the treatment of autoimmune diseases and disorders. SelectION is based in San Diego, CA and was founded in 2002. Its last reported valuation was $195 million in Jun 2023. It has raised $19.6 million across 4 recorded rounds; the latest was a $5.4 million early-stage round in Sep 2025.

Last reported valuation
$195.0M
Oct 2026
Priced at
—
Total raised
$19.6M
Last round
Early Stage VC
Sep 2025
How much has SelectION raised?
$19.6Macross 4 recorded rounds · May 2019 – Sep 2025

Most recently, SelectION raised $5.4M in its Early Stage VC (Sep 2025).

Free account
More of SelectION with a free account
  • ·Watch SelectION: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

SelectION round by round

4 rounds
Sep 2025Early Stage VC$5.4MSEC filing▮
5 investors participated
May 2023Early Stage VC$5.0MSEC filing▮
9 investors participated
Apr 2021Early Stage VC$5.1MSEC filing▮
11 investors participated
May 2019Seed Round$4.1MSEC filing▮
8 investors participated

How much has SelectION raised?

SelectION has raised $19.6 million across 4 recorded rounds since 2019. The largest was a $5.4 million early-stage round in Sep 2025.

SelectION has filed 4 Form Ds with the SEC since 2019, most recently in Sep 2025 ($5.4 million sold to 5 investors).

SelectION investors

6 investors are on record for SelectION, including Bay Area Biosciences Association, BioM Biotech Cluster Development, Bundesministerium für Bildung und Forschung and Global Source Ventures. The early-stage round in Sep 2025 drew 5 investors.

For fundraisers
Raising for a company like SelectION?

6 investors have backed SelectION.

See all 6 investors →

Frequently asked about SelectION

How much has SelectION raised?
SelectION has raised $19.6M in total across 4 recorded funding rounds.
When was SelectION's last funding round?
SelectION's most recent recorded round was Early Stage VC in Sep 2025, raising $5.4M.